Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound
old 15 18 15 18 O

Fasting 0 7 19 26 B-clinical_variable
LDL 8 11 27 30 I-clinical_variable
- 11 12 30 31 I-clinical_variable
cholesterol 12 23 31 42 I-clinical_variable
≥70 24 27 43 46 O
mg 28 30 47 49 I-lower_bound
/ 30 31 49 50 I-lower_bound
dL 31 33 50 52 I-lower_bound
or 34 36 53 55 O
a 37 38 56 57 O
non 39 42 58 61 B-clinical_variable
- 42 43 61 62 I-clinical_variable
high 43 47 62 66 I-clinical_variable
- 47 48 66 67 I-clinical_variable
density 48 55 67 74 I-clinical_variable
lipoprotein 56 67 75 86 I-clinical_variable
cholesterol 68 79 87 98 I-clinical_variable
( 80 81 99 100 I-clinical_variable
HDL 81 84 100 103 I-clinical_variable
- 84 85 103 104 I-clinical_variable
C 85 86 104 105 I-clinical_variable
) 86 87 105 106 I-clinical_variable
of 88 90 107 109 O
≥100 91 95 110 114 O
mg 96 98 115 117 I-lower_bound
/ 98 99 117 118 I-lower_bound
dL 99 101 118 120 I-lower_bound
after 102 107 121 126 O
≥2 108 110 127 129 O
weeks 111 116 130 135 I-lower_bound
of 117 119 136 138 O
optimized 120 129 139 148 O
stable 130 136 149 155 O
lipid 137 142 156 161 B-treatment
- 142 143 161 162 I-treatment
lowering 143 151 162 170 I-treatment
therapy 152 159 171 178 I-treatment
with 160 164 179 183 O
maximally 165 174 184 193 O
tolerated 175 184 194 203 O
dose 185 189 204 208 O
of 190 192 209 211 O
statin 193 199 212 218 O

Hemodynamic 0 11 219 230 B-chronic_disease
instability 12 23 231 242 I-chronic_disease

History 0 7 243 250 O
of 8 10 251 253 O
a 11 12 254 255 O
serious 13 20 256 263 O
hypersensitivity 21 37 264 280 O
reaction 38 46 281 289 O
to 47 49 290 292 O
evolocumab 50 60 293 303 B-allergy_name

On 0 2 304 306 O
therapy 3 10 307 314 B-treatment
with 11 15 315 319 I-treatment
clopidogrel 16 27 320 331 I-treatment
( 28 29 332 333 I-treatment
75 29 31 333 335 I-treatment
mg 31 33 335 337 I-treatment
od 34 36 338 340 I-treatment
) 36 37 340 341 I-treatment
, 37 38 341 342 I-treatment
with 39 43 343 347 I-treatment
or 44 46 348 350 I-treatment
without 47 54 351 358 I-treatment
low 55 58 359 362 I-treatment
- 58 59 362 363 I-treatment
dose 59 63 363 367 I-treatment
aspirin 64 71 368 375 I-treatment
( 72 73 376 377 I-treatment
81 73 75 377 379 I-treatment
mg 75 77 379 381 I-treatment
od 78 80 382 384 I-treatment
) 80 81 384 385 I-treatment
, 81 82 385 386 O
as 83 85 387 389 O
per 86 89 390 393 O
standard 90 98 394 402 O
- 98 99 402 403 O
of 99 101 403 405 O
- 101 102 405 406 O
care 102 106 406 410 O
for 107 110 411 414 O
at 111 113 415 417 O
least 114 119 418 423 O
30 120 122 424 426 B-lower_bound
days 123 127 427 431 I-lower_bound

On 0 2 432 434 O
treatment 3 12 435 444 B-treatment
with 13 17 445 449 O
any 18 21 450 453 O
antiplatelet 22 34 454 466 B-treatment
agent 35 40 467 472 I-treatment
other 41 46 473 478 O
than 47 51 479 483 O
aspirin 52 59 484 491 B-treatment
and 60 63 492 495 O
clopidogrel 64 75 496 507 B-treatment
in 76 78 508 510 O
the 79 82 511 514 O
past 83 87 515 519 B-upper_bound
14 88 90 520 522 I-upper_bound
days 91 95 523 527 I-upper_bound

On 0 2 528 530 O
treatment 3 12 531 540 O
with 13 17 541 545 O
any 18 21 546 549 O
oral 22 26 550 554 B-treatment
anticoagulant 27 40 555 568 I-treatment

PAD 0 3 569 572 B-chronic_disease
presumed 4 12 573 581 O
to 13 15 582 584 O
be 16 18 585 587 O
of 19 21 588 590 O
atherosclerotic 22 37 591 606 B-chronic_disease
origin 38 44 607 613 O

Patients 0 8 614 622 O
with 9 13 623 627 O
atherosclerotic 14 29 628 643 B-chronic_disease
cardiovascular 30 44 644 658 I-chronic_disease
disease 45 52 659 666 I-chronic_disease
( 53 54 667 668 I-chronic_disease
ASCVD 54 59 668 673 I-chronic_disease
) 59 60 673 674 I-chronic_disease
, 60 61 674 675 O
defined 62 69 676 683 O
as 70 72 684 686 O
prior 73 78 687 692 O
ACS 79 82 693 696 O

Pregnant 0 8 697 705 B-pregnancy
and 9 12 706 709 O
breastfeeding 13 26 710 723 O
women 27 32 724 729 B-gender
[ 33 34 730 731 O
women 34 39 731 736 O
of 40 42 737 739 O
childbearing 43 55 740 752 O
age 56 59 753 756 B-age
must 60 64 757 761 O
use 65 68 762 765 B-contraception_consent
reliable 69 77 766 774 I-contraception_consent
birth 78 83 775 780 I-contraception_consent
control 84 91 781 788 I-contraception_consent
( 92 93 789 790 O
i.e. 93 97 790 794 O
oral 98 102 795 799 B-contraception_consent
contraceptives 103 117 800 814 I-contraception_consent
) 117 118 814 815 O
while 119 124 816 821 O
participating 125 138 822 835 O
in 139 141 836 838 O
the 142 145 839 842 O
study 146 151 843 848 O
] 151 152 848 849 O

coronary 0 8 850 858 B-chronic_disease
or 9 11 859 861 O
other 12 17 862 867 O
arterial 18 26 868 876 B-chronic_disease
revascularization 27 44 877 894 I-chronic_disease

edoxaban 0 8 895 903 B-treatment

history 0 7 904 911 O
of 8 10 912 914 O
myocardial 11 21 915 925 B-chronic_disease
infarction 22 32 926 936 I-chronic_disease

rivaroxaban 0 11 937 948 B-treatment

stable 0 6 949 955 O
or 7 9 956 958 O
unstable 10 18 959 967 B-chronic_disease
angina 19 25 968 974 I-chronic_disease

stroke 0 6 975 981 B-chronic_disease

transient 0 9 982 991 B-chronic_disease
ischemic 10 18 992 1000 I-chronic_disease
attack 19 25 1001 1007 I-chronic_disease

vitamin 0 7 1008 1015 B-treatment
K 8 9 1016 1017 I-treatment
antagonists 10 21 1018 1029 I-treatment

